149 related articles for article (PubMed ID: 29914442)
1. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
[TBL] [Abstract][Full Text] [Related]
2. SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway.
Zhou C; Liu C; Liu W; Chen W; Yin Y; Li CW; Hsu JL; Sun J; Zhou Q; Li H; Hu B; Fu P; Atyah M; Ma Q; Xu Y; Dong Q; Hung MC; Ren N
Theranostics; 2020; 10(10):4627-4643. PubMed ID: 32292519
[TBL] [Abstract][Full Text] [Related]
3. TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma.
Yin YT; Shi L; Wu C; Zhang MY; Li JX; Zhou YF; Wang SC; Wang HY; Mai SJ
Med Oncol; 2024 Feb; 41(3):79. PubMed ID: 38393440
[TBL] [Abstract][Full Text] [Related]
4. Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.
Wang F; Xu WQ; Zhang WQ; Xu RC; Sun JL; Zhang GC; Liu ZY; Qi ZR; Dong L; Weng SQ; Shen XZ; Liu TT; Fang Y; Zhu JM
Hepatol Int; 2024 Apr; 18(2):636-650. PubMed ID: 37982952
[TBL] [Abstract][Full Text] [Related]
5. HJURP promotes hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways.
Chen T; Huang H; Zhou Y; Geng L; Shen T; Yin S; Zhou L; Zheng S
J Exp Clin Cancer Res; 2018 Aug; 37(1):193. PubMed ID: 30111352
[TBL] [Abstract][Full Text] [Related]
6. EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling.
Liu ZK; Li C; Zhang RY; Wei D; Shang YK; Yong YL; Kong LM; Zheng NS; Liu K; Lu M; Liu M; Hu CX; Yang XZ; Chen ZN; Bian H
Mol Cancer; 2021 May; 20(1):79. PubMed ID: 34044846
[TBL] [Abstract][Full Text] [Related]
7. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
[TBL] [Abstract][Full Text] [Related]
8. MiR-3150b inhibits hepatocellular carcinoma cell proliferation, migration and invasion by targeting GOLPH3.
Zhang Y; Wang J; Su H
J Investig Med; 2020 Mar; 68(3):770-775. PubMed ID: 31806673
[TBL] [Abstract][Full Text] [Related]
9. The E2F1/USP11 positive feedback loop promotes hepatocellular carcinoma metastasis and inhibits autophagy by activating ERK/mTOR pathway.
Qiao L; Zhang Q; Sun Z; Liu Q; Wu Z; Hu W; Bao S; Yang Q; Liu L
Cancer Lett; 2021 Aug; 514():63-78. PubMed ID: 34044068
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming.
Ji X; Yang Z; Li C; Zhu S; Zhang Y; Xue F; Sun S; Fu T; Ding C; Liu Y; Wan Q
Metabolism; 2024 Mar; 152():155761. PubMed ID: 38104924
[TBL] [Abstract][Full Text] [Related]
11. GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5.
Fu B; Meng W; Zhao H; Zhang B; Tang H; Zou Y; Yao J; Li H; Zhang T
Sci Rep; 2016 Sep; 6():31963. PubMed ID: 27585821
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK/mTOR signaling pathway.
Wu H; Qu L; Bai X; Zhu C; Liu Y; Duan Z; Liu H; Fu R; Fan D
Food Chem Toxicol; 2024 Apr; 186():114587. PubMed ID: 38461953
[TBL] [Abstract][Full Text] [Related]
13. Expression and Clinical Significance of Golgi Phosphoprotein 3 (GOLPH3) in Papillary Thyroid Carcinoma.
Yu WS; Zhou ZP; Zeng JF; Huang ZQ; Qiu CZ
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):324-330. PubMed ID: 36952588
[TBL] [Abstract][Full Text] [Related]
14. CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway.
Yang S; Peng LR; Yu AQ; Li J
Ann Hepatol; 2023; 28(5):101118. PubMed ID: 37268061
[TBL] [Abstract][Full Text] [Related]
15. GOLPH3 promotes endotoxemia-induced liver and kidney injury through Golgi stress-mediated apoptosis and inflammatory response.
Dusabimana T; Je J; Yun SP; Kim HJ; Kim H; Park SW
Cell Death Dis; 2023 Jul; 14(7):458. PubMed ID: 37479687
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide mononucleotide induces autophagy and ferroptosis via AMPK/mTOR pathway in hepatocellular carcinoma.
Sun Z; Liu L; Liang H; Zhang L
Mol Carcinog; 2024 Apr; 63(4):577-588. PubMed ID: 38197493
[TBL] [Abstract][Full Text] [Related]
17. Degradation of helicase-like transcription factor (HLTF) by β-TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis.
Tan Y; Wu D; Liu ZY; Yu HQ; Zheng XR; Lin XT; Bie P; Zhang LD; Xie CM
J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36822623
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma.
Li X; Zhang CC; Lin XT; Zhang J; Zhang YJ; Yu HQ; Liu ZY; Gong Y; Zhang LD; Xie CM
Exp Mol Med; 2024 Feb; 56(1):177-191. PubMed ID: 38177295
[TBL] [Abstract][Full Text] [Related]
19. B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.
Zhang X; Liu H; Wang H; Zhao R; Lu Q; Liu Y; Han Y; LuluRen ; Pan H; Han W
Cell Mol Life Sci; 2022 Dec; 80(1):8. PubMed ID: 36495345
[TBL] [Abstract][Full Text] [Related]
20. FARSB Facilitates Hepatocellular Carcinoma Progression by Activating the mTORC1 Signaling Pathway.
Wang Y; Wang G; Hu S; Yin C; Zhao P; Zhou X; Shao S; Liu R; Hu W; Liu GL; Ke W; Song Z
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
